Durability of SARS-CoV-2 Antibodies From Natural Infection in Children and Adolescents
Pediatrics
.
2022 Jun 1;149(6):e2021055505.
doi: 10.1542/peds.2021-055505.
Authors
Sarah E Messiah
1
2
3
,
Stacia M DeSantis
4
,
Luis G Leon-Novelo
4
,
Yashar Talebi
4
,
Frances A Brito
4
,
Harold W Kohl
5
6
,
Melissa A Valerio-Shewmaker
7
,
Jessica A Ross
4
,
Michael D Swartz
4
,
Ashraf Yaseen
4
,
Steven H Kelder
5
,
Shiming Zhang
4
,
Onyinye S Omega-Njemnobi
5
,
Michael O Gonzalez
4
,
Leqing Wu
4
,
Eric Boerwinkle
4
,
David L Lakey
6
,
Jennifer A Shuford
8
,
Stephen J Pont
8
Affiliations
1
Center for Pediatric Population Health.
2
The University of Texas Health Science Center at Houston, School of Public Health in Dallas, Dallas,Texas.
3
Children's Health System of Texas, Dallas, Texas.
4
The University of Texas Health Science Center at Houston, School of Public Health in Houston, Houston, Texas.
5
The University of Texas Health Science Center at Houston, School of Public Health in Austin, Austin, Texas.
6
The University of Texas System, Austin, Texas.
7
The University of Texas Health Science Center at Houston, School of Public Health in Brownsville, Brownsville, Texas.
8
Texas Department of State Health Services, Austin, Texas.
PMID:
35301530
DOI:
10.1542/peds.2021-055505
No abstract available
Publication types
Research Support, U.S. Gov't, Non-P.H.S.
Research Support, Non-U.S. Gov't
MeSH terms
Adolescent
Antibodies, Viral
COVID-19*
Child
Hospitalization
Humans
Immunologic Tests
SARS-CoV-2*
Substances
Antibodies, Viral